(In the media)Round-table Discussion; Pharmaceutical Industry in 2020 Part 2: The Time to Act is Now: People’s talk of the Conflict Between Promotion of New Drug Development and its Policies (Monthly Mix, the September 2016 edition)
date : 9/1/2016
An article featuring a “Round-table Discussion; Pharmaceutical Industry in 2020 Part 2: Images of an ideal medical representative during the years of community-based integrated care systems: The need to specify community members’ roles in their local area. Pharmaceutical companies and wholesalers need to work in co-operation to propose standard care solutions for local areas.” in which Toshio Miyata, HGPI Board Member participated, appeared in the September issue of Monthly Mix.
Proposals were made on how pharmaceutical companies and imaginative ideal medical representatives should support the local areas during the years of community-based integrated care systems
Katsufumi Jo ( Director of General Affairs Division, Ministry of Health, Labour and Welfare)
Isao Teshirogi (Representative Director, SHionogi & Co., LTD)
Toshio Miyata (Board Member, HGPI)
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] A Nationwide Survey on Cancer in Japan: 20 Years Since the Enactment of the Cancer Control Act (April 28, 2026)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)



